DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on May 27, 2008; DOI: 10.1124/dmd.107.019430


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.019430v1
36/8/1659    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Aloysius, H. A
Right arrow Articles by Tschirret-Guth, R. A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aloysius, H. A
Right arrow Articles by Tschirret-Guth, R. A


Received for publication October 26, 2007.
Revised May 21, 2008.
Accepted for publication May 21, 2008.

Comparative disposition and metabolism of paraherquamide in sheep, gerbils and dogs

Herve A Aloysius 1, Maria V Silva Elipe 1, Byron H Arison 1, Terry D Faidley 1, Bruce F Michael 1, Timothy A Blizzard 1, Donald R Thompson 1, Wesley L Shoop 1, Richard A Tschirret-Guth 1*

1 Merck Research Laboratories

* Address correspondence to: E-mail: richard_tschirretguth{at}merck.com

Abstract

The disposition and metabolism of paraherquamide (PHQ), a potent and broad spectrum anthelminthic, were examined in sheep, dogs and gerbils. The metabolism of PHQ in these species was extensive and marked by significant species differences both in vitro and in vivo. In sheep and gerbils, PHQ metabolism occurs mainly at the pyrrolidine moiety generating several metabolites that, for the most part, retained nematodicidal activity in vitro. In dogs the dioxepene group was also extensively metabolized, ultimately resulting in formation of a catechol and loss of pharmacological activity. After oral administration of [3H]PHQ to intact sheep, gerbils and dogs the majority of the administered radioactivity was recovered in feces. Intact PHQ accounted for 0% (dog) to 30% (sheep, gerbil) of drug-related material in feces. A detailed investigation of the composition of the intestinal content of sheep indicated that a significant amount of the dose was still present in the rumen 24 h post-dose and that PHQ underwent significant dehydration in the cecum. The oral pharmacokinetic parameters of PHQ in sheep and dogs suggests that its absorption is rapid in both species but that its apparent elimination rate is significantly higher in the dog (t1/2 {approx} 1.5 h) than it is in sheep (t1/2 {approx} 8.5 h). The short elimination half-life and the absence of PHQ or other active components in the dog gastro-intestinal tract provide a potential explanation of the lack of efficacy of PHQ in this species.


Key words: metabolite identification, pharmacokinetics, structure elucidation





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.